Previous Close | 2.5000 |
Open | 2.5350 |
Bid | 2.5050 x 0 |
Ask | 2.7700 x 0 |
Day's Range | 2.5350 - 2.7100 |
52 Week Range | 1.4480 - 4.3950 |
Volume | |
Avg. Volume | 0 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
The pharma will work with Triana Biomedicines on molecular glue degraders. Elsewhere, Akeso raised $250 million and a MASH drug developer got a well-known board chair.
Inventiva will gain a new chairman following the deal as it presses ahead with a Phase III trial for its lead asset.